Nurix Therapeutics (NRIX) Net Margin (2019 - 2026)
Nurix Therapeutics (NRIX) posted Net Margin of -990.10% for fiscal Q2 2026 (quarter ended May 31, 2026), down 891.45 percentage points from -98.66% a year earlier but up 404.23 percentage points from the prior quarter.
Nurix Therapeutics (NRIX) Net Margin (2019 - 2026) Analysis & Trends
For the trailing twelve months through May 31, 2026, Net Margin at Nurix Therapeutics was -928.44%, down 693.87 percentage points year-over-year; for FY2025 (ended Nov 30, 2025), it came in at -314.90%, up 39.95 percentage points from FY2024.
- Annual Net Margin shows a five-year change of -72.24 percentage points (FY2020 to FY2025).
- In prior fiscal years, Nurix Therapeutics' Net Margin was -354.85% in FY2024 (-167.88 pp), -186.98% in FY2023 (+279.95 pp), -466.93% in FY2022 (-73.00 pp) and -393.93% in FY2021 (-151.27 pp).
- Quarterly Net Margin has run from a low of -1394.34% in fiscal Q1 2026 to a high of -79.14% in fiscal Q2 2023 over five years.
- On a year-over-year basis, Net Margin has declined in each of the last four quarters, with an average year-over-year change of -369.95 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Net Margin in the past five years was fiscal Q4 2023, with a gain of 411.96 percentage points; the weakest was fiscal Q1 2026, with a drop of 1088.96 percentage points.
- According to Business Quant data, Net Margin for the three prior fiscal quarters was -1394.34% (Q1 2026), -576.13% (Q4 2025) and -1094.77% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Nurix Therapeutics | 2.45 Bn | 448.58 Mn | - | -990.10% |
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -990.10% |
| Feb 28, 2026 | -1,394.34% |
| Nov 30, 2025 | -576.13% |
| Aug 31, 2025 | -1,094.77% |
| May 31, 2025 | -98.66% |
| Feb 28, 2025 | -305.38% |
| Nov 30, 2024 | -440.75% |
| Aug 31, 2024 | -388.91% |
| May 31, 2024 | -368.39% |
| Feb 29, 2024 | -250.33% |
| Nov 30, 2023 | -276.77% |
| Aug 31, 2023 | -200.26% |
| May 31, 2023 | -79.14% |
| Feb 28, 2023 | -321.11% |
| Nov 30, 2022 | -688.74% |
| Aug 31, 2022 | -423.58% |
| May 31, 2022 | -397.14% |
| Feb 28, 2022 | -442.09% |
| Nov 30, 2021 | -509.76% |
| Aug 31, 2021 | -281.26% |
Nurix Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();